nodes	percent_of_prediction	percent_of_DWPC	metapath
Thiabendazole—Visual acuity reduced—Fingolimod—multiple sclerosis	0.0534	0.0534	CcSEcCtD
Thiabendazole—Liver injury—Fingolimod—multiple sclerosis	0.0377	0.0377	CcSEcCtD
Thiabendazole—Conjunctival hyperaemia—Prednisolone—multiple sclerosis	0.0221	0.0221	CcSEcCtD
Thiabendazole—Cholestasis—Azathioprine—multiple sclerosis	0.0193	0.0193	CcSEcCtD
Thiabendazole—Conjunctival hyperaemia—Betamethasone—multiple sclerosis	0.0184	0.0184	CcSEcCtD
Thiabendazole—Conjunctival hyperaemia—Dexamethasone—multiple sclerosis	0.0184	0.0184	CcSEcCtD
Thiabendazole—Liver injury—Azathioprine—multiple sclerosis	0.0174	0.0174	CcSEcCtD
Thiabendazole—Hepatocellular injury—Azathioprine—multiple sclerosis	0.0146	0.0146	CcSEcCtD
Thiabendazole—Hepatic failure—Cladribine—multiple sclerosis	0.0145	0.0145	CcSEcCtD
Thiabendazole—Visual acuity reduced—Betamethasone—multiple sclerosis	0.0136	0.0136	CcSEcCtD
Thiabendazole—Visual acuity reduced—Dexamethasone—multiple sclerosis	0.0136	0.0136	CcSEcCtD
Thiabendazole—Vision blurred—Fingolimod—multiple sclerosis	0.0131	0.0131	CcSEcCtD
Thiabendazole—Leukopenia—Fingolimod—multiple sclerosis	0.0124	0.0124	CcSEcCtD
Thiabendazole—Hepatic failure—Azathioprine—multiple sclerosis	0.0118	0.0118	CcSEcCtD
Thiabendazole—Hypotension—Fingolimod—multiple sclerosis	0.0106	0.0106	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Cladribine—multiple sclerosis	0.00998	0.00998	CcSEcCtD
Thiabendazole—Fatigue—Fingolimod—multiple sclerosis	0.00976	0.00976	CcSEcCtD
Thiabendazole—Erythema multiforme—Cladribine—multiple sclerosis	0.00854	0.00854	CcSEcCtD
Thiabendazole—Asthenia—Fingolimod—multiple sclerosis	0.00813	0.00813	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Azathioprine—multiple sclerosis	0.00811	0.00811	CcSEcCtD
Thiabendazole—Chills—Cladribine—multiple sclerosis	0.00811	0.00811	CcSEcCtD
Thiabendazole—Pruritus—Fingolimod—multiple sclerosis	0.00801	0.00801	CcSEcCtD
Thiabendazole—Diarrhoea—Fingolimod—multiple sclerosis	0.00775	0.00775	CcSEcCtD
Thiabendazole—Dizziness—Fingolimod—multiple sclerosis	0.00749	0.00749	CcSEcCtD
Thiabendazole—Headache—Fingolimod—multiple sclerosis	0.00709	0.00709	CcSEcCtD
Thiabendazole—Erythema multiforme—Azathioprine—multiple sclerosis	0.00695	0.00695	CcSEcCtD
Thiabendazole—Hyperglycaemia—Mitoxantrone—multiple sclerosis	0.00669	0.00669	CcSEcCtD
Thiabendazole—Drowsiness—Mitoxantrone—multiple sclerosis	0.00662	0.00662	CcSEcCtD
Thiabendazole—Chills—Azathioprine—multiple sclerosis	0.00659	0.00659	CcSEcCtD
Thiabendazole—Confusional state—Cladribine—multiple sclerosis	0.00647	0.00647	CcSEcCtD
Thiabendazole—Jaundice—Mitoxantrone—multiple sclerosis	0.00645	0.00645	CcSEcCtD
Thiabendazole—Haematuria—Mitoxantrone—multiple sclerosis	0.00631	0.00631	CcSEcCtD
Thiabendazole—Anorexia—Cladribine—multiple sclerosis	0.00612	0.00612	CcSEcCtD
Thiabendazole—Hypotension—Cladribine—multiple sclerosis	0.006	0.006	CcSEcCtD
Thiabendazole—Leukopenia—Azathioprine—multiple sclerosis	0.00572	0.00572	CcSEcCtD
Thiabendazole—Somnolence—Cladribine—multiple sclerosis	0.00571	0.00571	CcSEcCtD
Thiabendazole—Decreased appetite—Cladribine—multiple sclerosis	0.00558	0.00558	CcSEcCtD
Thiabendazole—Fatigue—Cladribine—multiple sclerosis	0.00553	0.00553	CcSEcCtD
Thiabendazole—Chills—Mitoxantrone—multiple sclerosis	0.00533	0.00533	CcSEcCtD
Thiabendazole—Feeling abnormal—Cladribine—multiple sclerosis	0.00529	0.00529	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Cladribine—multiple sclerosis	0.00525	0.00525	CcSEcCtD
Thiabendazole—Abdominal pain—Cladribine—multiple sclerosis	0.00507	0.00507	CcSEcCtD
Thiabendazole—Lymphadenopathy—Methotrexate—multiple sclerosis	0.00501	0.00501	CcSEcCtD
Thiabendazole—Hypotension—Azathioprine—multiple sclerosis	0.00488	0.00488	CcSEcCtD
Thiabendazole—Vision blurred—Mitoxantrone—multiple sclerosis	0.00487	0.00487	CcSEcCtD
Thiabendazole—Hepatic failure—Methotrexate—multiple sclerosis	0.00476	0.00476	CcSEcCtD
Thiabendazole—Hypersensitivity—Cladribine—multiple sclerosis	0.00473	0.00473	CcSEcCtD
Thiabendazole—Visual impairment—Prednisolone—multiple sclerosis	0.0047	0.0047	CcSEcCtD
Thiabendazole—Leukopenia—Mitoxantrone—multiple sclerosis	0.00463	0.00463	CcSEcCtD
Thiabendazole—Asthenia—Cladribine—multiple sclerosis	0.00461	0.00461	CcSEcCtD
Thiabendazole—Hyperglycaemia—Dexamethasone—multiple sclerosis	0.00458	0.00458	CcSEcCtD
Thiabendazole—Hyperglycaemia—Betamethasone—multiple sclerosis	0.00458	0.00458	CcSEcCtD
Thiabendazole—Pruritus—Cladribine—multiple sclerosis	0.00454	0.00454	CcSEcCtD
Thiabendazole—Convulsion—Mitoxantrone—multiple sclerosis	0.00448	0.00448	CcSEcCtD
Thiabendazole—Diarrhoea—Cladribine—multiple sclerosis	0.00439	0.00439	CcSEcCtD
Thiabendazole—Visual impairment—Methylprednisolone—multiple sclerosis	0.00431	0.00431	CcSEcCtD
Thiabendazole—Feeling abnormal—Azathioprine—multiple sclerosis	0.0043	0.0043	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00427	0.00427	CcSEcCtD
Thiabendazole—Confusional state—Mitoxantrone—multiple sclerosis	0.00425	0.00425	CcSEcCtD
Thiabendazole—Dizziness—Cladribine—multiple sclerosis	0.00425	0.00425	CcSEcCtD
Thiabendazole—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.00422	0.00422	CcSEcCtD
Thiabendazole—Abdominal pain—Azathioprine—multiple sclerosis	0.00413	0.00413	CcSEcCtD
Thiabendazole—Vomiting—Cladribine—multiple sclerosis	0.00408	0.00408	CcSEcCtD
Thiabendazole—Rash—Cladribine—multiple sclerosis	0.00405	0.00405	CcSEcCtD
Thiabendazole—Dermatitis—Cladribine—multiple sclerosis	0.00404	0.00404	CcSEcCtD
Thiabendazole—Anorexia—Mitoxantrone—multiple sclerosis	0.00402	0.00402	CcSEcCtD
Thiabendazole—Headache—Cladribine—multiple sclerosis	0.00402	0.00402	CcSEcCtD
Thiabendazole—Vision blurred—Prednisolone—multiple sclerosis	0.004	0.004	CcSEcCtD
Thiabendazole—Hyperglycaemia—Prednisone—multiple sclerosis	0.00399	0.00399	CcSEcCtD
Thiabendazole—Hypotension—Mitoxantrone—multiple sclerosis	0.00394	0.00394	CcSEcCtD
Thiabendazole—Visual impairment—Dexamethasone—multiple sclerosis	0.00392	0.00392	CcSEcCtD
Thiabendazole—Visual impairment—Betamethasone—multiple sclerosis	0.00392	0.00392	CcSEcCtD
Thiabendazole—Angioedema—Prednisolone—multiple sclerosis	0.00388	0.00388	CcSEcCtD
Thiabendazole—Hypersensitivity—Azathioprine—multiple sclerosis	0.00385	0.00385	CcSEcCtD
Thiabendazole—Nausea—Cladribine—multiple sclerosis	0.00381	0.00381	CcSEcCtD
Thiabendazole—Somnolence—Mitoxantrone—multiple sclerosis	0.00375	0.00375	CcSEcCtD
Thiabendazole—Dyspepsia—Mitoxantrone—multiple sclerosis	0.00371	0.00371	CcSEcCtD
Thiabendazole—Convulsion—Prednisolone—multiple sclerosis	0.00368	0.00368	CcSEcCtD
Thiabendazole—Decreased appetite—Mitoxantrone—multiple sclerosis	0.00367	0.00367	CcSEcCtD
Thiabendazole—Fatigue—Mitoxantrone—multiple sclerosis	0.00364	0.00364	CcSEcCtD
Thiabendazole—Diarrhoea—Azathioprine—multiple sclerosis	0.00357	0.00357	CcSEcCtD
Thiabendazole—Angioedema—Triamcinolone—multiple sclerosis	0.00356	0.00356	CcSEcCtD
Thiabendazole—Angioedema—Methylprednisolone—multiple sclerosis	0.00356	0.00356	CcSEcCtD
Thiabendazole—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.00348	0.00348	CcSEcCtD
Thiabendazole—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00346	0.00346	CcSEcCtD
Thiabendazole—Dizziness—Azathioprine—multiple sclerosis	0.00345	0.00345	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00345	0.00345	CcSEcCtD
Thiabendazole—Convulsion—Triamcinolone—multiple sclerosis	0.00338	0.00338	CcSEcCtD
Thiabendazole—Convulsion—Methylprednisolone—multiple sclerosis	0.00337	0.00337	CcSEcCtD
Thiabendazole—Abdominal pain—Mitoxantrone—multiple sclerosis	0.00334	0.00334	CcSEcCtD
Thiabendazole—Vomiting—Azathioprine—multiple sclerosis	0.00332	0.00332	CcSEcCtD
Thiabendazole—Drowsiness—Methotrexate—multiple sclerosis	0.0033	0.0033	CcSEcCtD
Thiabendazole—Rash—Azathioprine—multiple sclerosis	0.00329	0.00329	CcSEcCtD
Thiabendazole—Dermatitis—Azathioprine—multiple sclerosis	0.00329	0.00329	CcSEcCtD
Thiabendazole—Flushing—Prednisone—multiple sclerosis	0.00329	0.00329	CcSEcCtD
Thiabendazole—Headache—Azathioprine—multiple sclerosis	0.00327	0.00327	CcSEcCtD
Thiabendazole—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.00327	0.00327	CcSEcCtD
Thiabendazole—Angioedema—Betamethasone—multiple sclerosis	0.00323	0.00323	CcSEcCtD
Thiabendazole—Angioedema—Dexamethasone—multiple sclerosis	0.00323	0.00323	CcSEcCtD
Thiabendazole—Confusional state—Methylprednisolone—multiple sclerosis	0.0032	0.0032	CcSEcCtD
Thiabendazole—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.00318	0.00318	CcSEcCtD
Thiabendazole—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.00318	0.00318	CcSEcCtD
Thiabendazole—Haematuria—Methotrexate—multiple sclerosis	0.00314	0.00314	CcSEcCtD
Thiabendazole—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00311	0.00311	CcSEcCtD
Thiabendazole—Nausea—Azathioprine—multiple sclerosis	0.0031	0.0031	CcSEcCtD
Thiabendazole—Convulsion—Dexamethasone—multiple sclerosis	0.00307	0.00307	CcSEcCtD
Thiabendazole—Convulsion—Betamethasone—multiple sclerosis	0.00307	0.00307	CcSEcCtD
Thiabendazole—Asthenia—Mitoxantrone—multiple sclerosis	0.00303	0.00303	CcSEcCtD
Thiabendazole—Hypotension—Methylprednisolone—multiple sclerosis	0.00297	0.00297	CcSEcCtD
Thiabendazole—Vision blurred—Prednisone—multiple sclerosis	0.0029	0.0029	CcSEcCtD
Thiabendazole—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00289	0.00289	CcSEcCtD
Thiabendazole—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00289	0.00289	CcSEcCtD
Thiabendazole—Diarrhoea—Mitoxantrone—multiple sclerosis	0.00289	0.00289	CcSEcCtD
Thiabendazole—Feeling abnormal—Prednisolone—multiple sclerosis	0.00285	0.00285	CcSEcCtD
Thiabendazole—Visual impairment—Methotrexate—multiple sclerosis	0.00285	0.00285	CcSEcCtD
Thiabendazole—Angioedema—Prednisone—multiple sclerosis	0.00282	0.00282	CcSEcCtD
Thiabendazole—Dyspepsia—Triamcinolone—multiple sclerosis	0.0028	0.0028	CcSEcCtD
Thiabendazole—Erythema multiforme—Methotrexate—multiple sclerosis	0.0028	0.0028	CcSEcCtD
Thiabendazole—Dyspepsia—Methylprednisolone—multiple sclerosis	0.0028	0.0028	CcSEcCtD
Thiabendazole—Tinnitus—Methotrexate—multiple sclerosis	0.00276	0.00276	CcSEcCtD
Thiabendazole—Anorexia—Dexamethasone—multiple sclerosis	0.00275	0.00275	CcSEcCtD
Thiabendazole—Anorexia—Betamethasone—multiple sclerosis	0.00275	0.00275	CcSEcCtD
Thiabendazole—Fatigue—Triamcinolone—multiple sclerosis	0.00274	0.00274	CcSEcCtD
Thiabendazole—Fatigue—Methylprednisolone—multiple sclerosis	0.00274	0.00274	CcSEcCtD
Thiabendazole—Hypotension—Betamethasone—multiple sclerosis	0.0027	0.0027	CcSEcCtD
Thiabendazole—Hypotension—Dexamethasone—multiple sclerosis	0.0027	0.0027	CcSEcCtD
Thiabendazole—Vomiting—Mitoxantrone—multiple sclerosis	0.00268	0.00268	CcSEcCtD
Thiabendazole—Convulsion—Prednisone—multiple sclerosis	0.00267	0.00267	CcSEcCtD
Thiabendazole—Rash—Mitoxantrone—multiple sclerosis	0.00266	0.00266	CcSEcCtD
Thiabendazole—Dermatitis—Mitoxantrone—multiple sclerosis	0.00266	0.00266	CcSEcCtD
Thiabendazole—Chills—Methotrexate—multiple sclerosis	0.00266	0.00266	CcSEcCtD
Thiabendazole—Headache—Mitoxantrone—multiple sclerosis	0.00264	0.00264	CcSEcCtD
Thiabendazole—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00262	0.00262	CcSEcCtD
Thiabendazole—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00262	0.00262	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.0026	0.0026	CcSEcCtD
Thiabendazole—Hypersensitivity—Prednisolone—multiple sclerosis	0.00255	0.00255	CcSEcCtD
Thiabendazole—Dyspepsia—Dexamethasone—multiple sclerosis	0.00254	0.00254	CcSEcCtD
Thiabendazole—Dyspepsia—Betamethasone—multiple sclerosis	0.00254	0.00254	CcSEcCtD
Thiabendazole—Anaphylactic shock—Prednisone—multiple sclerosis	0.00252	0.00252	CcSEcCtD
Thiabendazole—Abdominal pain—Methylprednisolone—multiple sclerosis	0.00251	0.00251	CcSEcCtD
Thiabendazole—Decreased appetite—Dexamethasone—multiple sclerosis	0.00251	0.00251	CcSEcCtD
Thiabendazole—Decreased appetite—Betamethasone—multiple sclerosis	0.00251	0.00251	CcSEcCtD
Thiabendazole—Nausea—Mitoxantrone—multiple sclerosis	0.00251	0.00251	CcSEcCtD
Thiabendazole—Fatigue—Betamethasone—multiple sclerosis	0.00249	0.00249	CcSEcCtD
Thiabendazole—Fatigue—Dexamethasone—multiple sclerosis	0.00249	0.00249	CcSEcCtD
Thiabendazole—Vision blurred—Methotrexate—multiple sclerosis	0.00243	0.00243	CcSEcCtD
Thiabendazole—Anorexia—Prednisone—multiple sclerosis	0.0024	0.0024	CcSEcCtD
Thiabendazole—Feeling abnormal—Dexamethasone—multiple sclerosis	0.00238	0.00238	CcSEcCtD
Thiabendazole—Feeling abnormal—Betamethasone—multiple sclerosis	0.00238	0.00238	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00236	0.00236	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00236	0.00236	CcSEcCtD
Thiabendazole—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00235	0.00235	CcSEcCtD
Thiabendazole—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.00234	0.00234	CcSEcCtD
Thiabendazole—Leukopenia—Methotrexate—multiple sclerosis	0.00231	0.00231	CcSEcCtD
Thiabendazole—Dizziness—Prednisolone—multiple sclerosis	0.00229	0.00229	CcSEcCtD
Thiabendazole—Asthenia—Triamcinolone—multiple sclerosis	0.00228	0.00228	CcSEcCtD
Thiabendazole—Abdominal pain—Betamethasone—multiple sclerosis	0.00228	0.00228	CcSEcCtD
Thiabendazole—Abdominal pain—Dexamethasone—multiple sclerosis	0.00228	0.00228	CcSEcCtD
Thiabendazole—Asthenia—Methylprednisolone—multiple sclerosis	0.00228	0.00228	CcSEcCtD
Thiabendazole—Pruritus—Triamcinolone—multiple sclerosis	0.00225	0.00225	CcSEcCtD
Thiabendazole—Pruritus—Methylprednisolone—multiple sclerosis	0.00225	0.00225	CcSEcCtD
Thiabendazole—Convulsion—Methotrexate—multiple sclerosis	0.00223	0.00223	CcSEcCtD
Thiabendazole—Dyspepsia—Prednisone—multiple sclerosis	0.00221	0.00221	CcSEcCtD
Thiabendazole—Decreased appetite—Prednisone—multiple sclerosis	0.00219	0.00219	CcSEcCtD
Thiabendazole—Rash—Prednisolone—multiple sclerosis	0.00218	0.00218	CcSEcCtD
Thiabendazole—Dermatitis—Prednisolone—multiple sclerosis	0.00218	0.00218	CcSEcCtD
Thiabendazole—Diarrhoea—Methylprednisolone—multiple sclerosis	0.00217	0.00217	CcSEcCtD
Thiabendazole—Fatigue—Prednisone—multiple sclerosis	0.00217	0.00217	CcSEcCtD
Thiabendazole—Headache—Prednisolone—multiple sclerosis	0.00217	0.00217	CcSEcCtD
Thiabendazole—Confusional state—Methotrexate—multiple sclerosis	0.00212	0.00212	CcSEcCtD
Thiabendazole—Dizziness—Triamcinolone—multiple sclerosis	0.00211	0.00211	CcSEcCtD
Thiabendazole—Anaphylactic shock—Methotrexate—multiple sclerosis	0.0021	0.0021	CcSEcCtD
Thiabendazole—Dizziness—Methylprednisolone—multiple sclerosis	0.0021	0.0021	CcSEcCtD
Thiabendazole—Feeling abnormal—Prednisone—multiple sclerosis	0.00207	0.00207	CcSEcCtD
Thiabendazole—Asthenia—Dexamethasone—multiple sclerosis	0.00207	0.00207	CcSEcCtD
Thiabendazole—Asthenia—Betamethasone—multiple sclerosis	0.00207	0.00207	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00206	0.00206	CcSEcCtD
Thiabendazole—Nausea—Prednisolone—multiple sclerosis	0.00206	0.00206	CcSEcCtD
Thiabendazole—Pruritus—Betamethasone—multiple sclerosis	0.00204	0.00204	CcSEcCtD
Thiabendazole—Pruritus—Dexamethasone—multiple sclerosis	0.00204	0.00204	CcSEcCtD
Thiabendazole—Vomiting—Triamcinolone—multiple sclerosis	0.00202	0.00202	CcSEcCtD
Thiabendazole—Vomiting—Methylprednisolone—multiple sclerosis	0.00202	0.00202	CcSEcCtD
Thiabendazole—Rash—Triamcinolone—multiple sclerosis	0.00201	0.00201	CcSEcCtD
Thiabendazole—Dermatitis—Triamcinolone—multiple sclerosis	0.00201	0.00201	CcSEcCtD
Thiabendazole—Anorexia—Methotrexate—multiple sclerosis	0.002	0.002	CcSEcCtD
Thiabendazole—Rash—Methylprednisolone—multiple sclerosis	0.002	0.002	CcSEcCtD
Thiabendazole—Dermatitis—Methylprednisolone—multiple sclerosis	0.002	0.002	CcSEcCtD
Thiabendazole—Headache—Triamcinolone—multiple sclerosis	0.00199	0.00199	CcSEcCtD
Thiabendazole—Headache—Methylprednisolone—multiple sclerosis	0.00199	0.00199	CcSEcCtD
Thiabendazole—Abdominal pain—Prednisone—multiple sclerosis	0.00199	0.00199	CcSEcCtD
Thiabendazole—Diarrhoea—Betamethasone—multiple sclerosis	0.00198	0.00198	CcSEcCtD
Thiabendazole—Diarrhoea—Dexamethasone—multiple sclerosis	0.00198	0.00198	CcSEcCtD
Thiabendazole—Hypotension—Methotrexate—multiple sclerosis	0.00196	0.00196	CcSEcCtD
Thiabendazole—Dizziness—Dexamethasone—multiple sclerosis	0.00191	0.00191	CcSEcCtD
Thiabendazole—Dizziness—Betamethasone—multiple sclerosis	0.00191	0.00191	CcSEcCtD
Thiabendazole—Nausea—Triamcinolone—multiple sclerosis	0.00189	0.00189	CcSEcCtD
Thiabendazole—Nausea—Methylprednisolone—multiple sclerosis	0.00189	0.00189	CcSEcCtD
Thiabendazole—Somnolence—Methotrexate—multiple sclerosis	0.00187	0.00187	CcSEcCtD
Thiabendazole—Hypersensitivity—Prednisone—multiple sclerosis	0.00185	0.00185	CcSEcCtD
Thiabendazole—Dyspepsia—Methotrexate—multiple sclerosis	0.00185	0.00185	CcSEcCtD
Thiabendazole—Vomiting—Betamethasone—multiple sclerosis	0.00184	0.00184	CcSEcCtD
Thiabendazole—Vomiting—Dexamethasone—multiple sclerosis	0.00184	0.00184	CcSEcCtD
Thiabendazole—Decreased appetite—Methotrexate—multiple sclerosis	0.00183	0.00183	CcSEcCtD
Thiabendazole—Rash—Dexamethasone—multiple sclerosis	0.00182	0.00182	CcSEcCtD
Thiabendazole—Rash—Betamethasone—multiple sclerosis	0.00182	0.00182	CcSEcCtD
Thiabendazole—Dermatitis—Betamethasone—multiple sclerosis	0.00182	0.00182	CcSEcCtD
Thiabendazole—Dermatitis—Dexamethasone—multiple sclerosis	0.00182	0.00182	CcSEcCtD
Thiabendazole—Fatigue—Methotrexate—multiple sclerosis	0.00181	0.00181	CcSEcCtD
Thiabendazole—Headache—Betamethasone—multiple sclerosis	0.00181	0.00181	CcSEcCtD
Thiabendazole—Headache—Dexamethasone—multiple sclerosis	0.00181	0.00181	CcSEcCtD
Thiabendazole—Asthenia—Prednisone—multiple sclerosis	0.0018	0.0018	CcSEcCtD
Thiabendazole—Pruritus—Prednisone—multiple sclerosis	0.00178	0.00178	CcSEcCtD
Thiabendazole—Feeling abnormal—Methotrexate—multiple sclerosis	0.00173	0.00173	CcSEcCtD
Thiabendazole—Diarrhoea—Prednisone—multiple sclerosis	0.00172	0.00172	CcSEcCtD
Thiabendazole—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.00172	0.00172	CcSEcCtD
Thiabendazole—Nausea—Dexamethasone—multiple sclerosis	0.00172	0.00172	CcSEcCtD
Thiabendazole—Nausea—Betamethasone—multiple sclerosis	0.00172	0.00172	CcSEcCtD
Thiabendazole—Dizziness—Prednisone—multiple sclerosis	0.00166	0.00166	CcSEcCtD
Thiabendazole—Abdominal pain—Methotrexate—multiple sclerosis	0.00166	0.00166	CcSEcCtD
Thiabendazole—Vomiting—Prednisone—multiple sclerosis	0.0016	0.0016	CcSEcCtD
Thiabendazole—Rash—Prednisone—multiple sclerosis	0.00159	0.00159	CcSEcCtD
Thiabendazole—Dermatitis—Prednisone—multiple sclerosis	0.00158	0.00158	CcSEcCtD
Thiabendazole—Headache—Prednisone—multiple sclerosis	0.00158	0.00158	CcSEcCtD
Thiabendazole—Hypersensitivity—Methotrexate—multiple sclerosis	0.00155	0.00155	CcSEcCtD
Thiabendazole—Asthenia—Methotrexate—multiple sclerosis	0.00151	0.00151	CcSEcCtD
Thiabendazole—Nausea—Prednisone—multiple sclerosis	0.00149	0.00149	CcSEcCtD
Thiabendazole—Pruritus—Methotrexate—multiple sclerosis	0.00149	0.00149	CcSEcCtD
Thiabendazole—Diarrhoea—Methotrexate—multiple sclerosis	0.00144	0.00144	CcSEcCtD
Thiabendazole—Dizziness—Methotrexate—multiple sclerosis	0.00139	0.00139	CcSEcCtD
Thiabendazole—Vomiting—Methotrexate—multiple sclerosis	0.00134	0.00134	CcSEcCtD
Thiabendazole—Rash—Methotrexate—multiple sclerosis	0.00133	0.00133	CcSEcCtD
Thiabendazole—Dermatitis—Methotrexate—multiple sclerosis	0.00132	0.00132	CcSEcCtD
Thiabendazole—Headache—Methotrexate—multiple sclerosis	0.00132	0.00132	CcSEcCtD
Thiabendazole—Nausea—Methotrexate—multiple sclerosis	0.00125	0.00125	CcSEcCtD
